Covidien to modify Optimark labeling

Healthcare technology firm Covidien said it will voluntarily contraindicate (more)

source : www.auntminnie.com

Related News:

• Covidien shows mixed results in Q4, fiscal 2009
• Covidien Introduces First FDA Approved Spine Sealant
• Covidien retools, sells sleep unit
• Covidien says Dutch isotope reactor running again
• Covidien Features New Devices For Minimally Invasive Surgery And Soft Tissue Repair At ASMBS 2009
• Covidien to acquire VNUS for $440M
• Covidien adds to Q2 sales
• Covidien, B&W to tackle medical isotope dilemma
• FDA Requires Labeling Change For Some Drugs Used To Prevent Rejection Of Kidney Transplants
• FDA approves 12-month labeling for Evolence collagen-based facial filler

Details :
Submited at Tuesday, November 10th, 2009 at 1:00 am on Radiology by ethan
Comment RSS 2.0 - leave a comment - trackback